Stay updated on Intranasal Etripamil Safety Study for PSVT Clinical Trial
Sign up to get notified when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.

Latest updates to the Intranasal Etripamil Safety Study for PSVT Clinical Trial page
- Check4 days agoChange DetectedThe NODE-302 record is displayed with its study design, eligibility criteria, outcomes, locations, results-related dates, and study documents. It identifies the study as terminated and no longer recruiting participants.SummaryDifference65%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page otherwise remains a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check25 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record with an access-denied notice and a basic header indicating an error state.SummaryDifference18%

Stay in the know with updates to Intranasal Etripamil Safety Study for PSVT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.